A Weissman1, L Gotlieb, R F Casper. 1. Department of Obstetrics and Gynecology, Toronto Hospital, University of Toronto, Ontario, Canada.
Abstract
OBJECTIVE: To determine whether there is a maximal value for endometrial thickness, as measured on the day of hCG administration, above which implantation and pregnancy are unlikely to occur. DESIGN: Retrospective analysis. SETTING: A university-based tertiary care center for assisted reproductive technology. PATIENT(S): A total of 809 IVF cycles in 623 patients resulting in ET. INTERVENTION(S): Endometrial thickness was measured by means of transvaginal ultrasound on the day of hCG administration. Cycles were divided into two groups based on endometrial thickness. Group A consisted of 680 cycles with "normal" endometrial thickness (7-14 mm), and group B included 37 cycles with "increased endometrial thickness" (>14 mm). MAIN OUTCOME MEASURE(S): Implantation, clinical pregnancy and miscarriage rates. RESULT(S): Group B cycles had significantly lower implantation and pregnancy rates compared with group A (3% versus 15% and 8.1% versus 29.7%, respectively). Two of 3 pregnancies (66.6%) from group B miscarried, compared with 44 of 202 (21.8%) pregnancies in group A. CONCLUSION(S): Patients with endometrial thickness of > 14 mm on the day of hCG administration comprise approximately 5% of the patients who undergo ET in our program. Our experience suggests that implantation and pregnancy rates are significantly reduced, and miscarriage rates may be increased in this group.
OBJECTIVE: To determine whether there is a maximal value for endometrial thickness, as measured on the day of hCG administration, above which implantation and pregnancy are unlikely to occur. DESIGN: Retrospective analysis. SETTING: A university-based tertiary care center for assisted reproductive technology. PATIENT(S): A total of 809 IVF cycles in 623 patients resulting in ET. INTERVENTION(S): Endometrial thickness was measured by means of transvaginal ultrasound on the day of hCG administration. Cycles were divided into two groups based on endometrial thickness. Group A consisted of 680 cycles with "normal" endometrial thickness (7-14 mm), and group B included 37 cycles with "increased endometrial thickness" (>14 mm). MAIN OUTCOME MEASURE(S): Implantation, clinical pregnancy and miscarriage rates. RESULT(S): Group B cycles had significantly lower implantation and pregnancy rates compared with group A (3% versus 15% and 8.1% versus 29.7%, respectively). Two of 3 pregnancies (66.6%) from group B miscarried, compared with 44 of 202 (21.8%) pregnancies in group A. CONCLUSION(S): Patients with endometrial thickness of > 14 mm on the day of hCG administration comprise approximately 5% of the patients who undergo ET in our program. Our experience suggests that implantation and pregnancy rates are significantly reduced, and miscarriage rates may be increased in this group.
Authors: Emily C Holden; Laura E Dodge; Rita Sneeringer; Vasiliki A Moragianni; Alan S Penzias; Michele R Hacker Journal: Hum Fertil (Camb) Date: 2017-06-18 Impact factor: 2.767
Authors: Julian A Gingold; Joseph A Lee; Jorge Rodriguez-Purata; Michael C Whitehouse; Benjamin Sandler; Lawrence Grunfeld; Tanmoy Mukherjee; Alan B Copperman Journal: Fertil Steril Date: 2015-06-13 Impact factor: 7.329